发明授权
US08268832B2 Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
有权
5 - [(4-甲基-1-哌嗪基)羰基氧基] -7-氧代-6,7-二氢-5H-吡咯并[3,4-b] 吡嗪
- 专利标题: Maleate salts of 6-(5-chloro-2-Pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
- 专利标题(中): 5 - [(4-甲基-1-哌嗪基)羰基氧基] -7-氧代-6,7-二氢-5H-吡咯并[3,4-b] 吡嗪
-
申请号: US12338908申请日: 2008-12-18
-
公开(公告)号: US08268832B2公开(公告)日: 2012-09-18
- 发明人: H. Scott Wilkinson , Richard Hsia , Tushar Misra , Kostas Saranteas , Patrick Mousaw
- 申请人: H. Scott Wilkinson , Richard Hsia , Tushar Misra , Kostas Saranteas , Patrick Mousaw
- 申请人地址: US MA Marlborough
- 专利权人: Sunovion Pharmaceuticals Inc.
- 当前专利权人: Sunovion Pharmaceuticals Inc.
- 当前专利权人地址: US MA Marlborough
- 代理机构: Heslin Rothenberg Farley & Mesiti P.C.
- 主分类号: A61K31/4965
- IPC分类号: A61K31/4965
摘要:
Pharmaceutical compositions of maleate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b]pyrazine) are provided. The maleate salts are sleep agents useful in oral dosage forms.
公开/授权文献
信息查询